Description
DescriptionRetatrutide is a “triple-agonist” peptide targeting GLP-1, GIP, and glucagon receptors.
BenefitsRepresents the cutting edge of metabolic research, investigated for its potent effects on weight loss, lipid metabolism, and glucose regulation by engaging three distinct hormonal pathways.
DisclaimerRetatrutide is a research laboratory-grade peptide compound produced under controlled conditions for analytical and scientific research. Each batch is purity-tested to ensure reliable and consistent study results. Not for human or veterinary consumption.
